These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 23600840
21. Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis. Kägi MK, Joller-Jemelka H, Wüthrich B. Dermatology; 1992; 185(2):88-92. PubMed ID: 1421636 [Abstract] [Full Text] [Related]
22. Quantitative analysis of nerve growth factor (NGF) in the atopic dermatitis and psoriasis horny layer and effect of treatment on NGF in atopic dermatitis. Yamaguchi J, Aihara M, Kobayashi Y, Kambara T, Ikezawa Z. J Dermatol Sci; 2009 Jan; 53(1):48-54. PubMed ID: 18922683 [Abstract] [Full Text] [Related]
23. FoxP3-expressing T regulatory cells in atopic dermatitis lesions. Caproni M, Antiga E, Torchia D, Volpi W, Barletta E, Gitti G, De Campora E, Fabbri P. Allergy Asthma Proc; 2007 Jan; 28(5):525-8. PubMed ID: 18034969 [Abstract] [Full Text] [Related]
25. Cutaneous T-cell lymphoma and concomitant atopic dermatitis responding to dupilumab. Mollanazar NK, Savage KT, Pousti BT, Jariwala N, Del Guzzo C, Haun P, Vittorio C, Rook AH, Kim EJ. Cutis; 2020 Sep; 106(3):131-132. PubMed ID: 33104116 [Abstract] [Full Text] [Related]
26. Increased CCL18 expression in patients with cutaneous T-cell lymphoma: association with disease severity and prognosis. Miyagaki T, Sugaya M, Suga H, Ohmatsu H, Fujita H, Asano Y, Tada Y, Kadono T, Sato S. J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e60-7. PubMed ID: 22404649 [Abstract] [Full Text] [Related]
27. Characterization of chemokine receptor expression and cytokine production in circulating CD4+ T cells from patients with atopic dermatitis: up-regulation of C-C chemokine receptor 4 in atopic dermatitis. Okazaki H, Kakurai M, Hirata D, Sato H, Kamimura T, Onai N, Matsushima K, Nakagawa H, Kano S, Minota S. Clin Exp Allergy; 2002 Aug; 32(8):1236-42. PubMed ID: 12190665 [Abstract] [Full Text] [Related]
28. FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival. Gjerdrum LM, Woetmann A, Odum N, Burton CM, Rossen K, Skovgaard GL, Ryder LP, Ralfkiaer E. Leukemia; 2007 Dec; 21(12):2512-8. PubMed ID: 17713545 [Abstract] [Full Text] [Related]
29. IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma. Miyagaki T, Sugaya M, Suga H, Kamata M, Ohmatsu H, Fujita H, Asano Y, Tada Y, Kadono T, Sato S. Clin Cancer Res; 2011 Dec 15; 17(24):7529-38. PubMed ID: 22048239 [Abstract] [Full Text] [Related]
30. Soluble interleukin-2 receptors inhibit interleukin 2-dependent proliferation and cytotoxicity: explanation for diminished natural killer cell activity in cutaneous T-cell lymphomas in vivo? Dummer R, Posseckert G, Nestle F, Witzgall R, Burger M, Becker JC, Schäfer E, Wiede J, Sebald W, Burg G. J Invest Dermatol; 1992 Jan 15; 98(1):50-4. PubMed ID: 1728640 [Abstract] [Full Text] [Related]
31. Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study. Hasan I, Parsons L, Duran S, Zinn Z. J Am Acad Dermatol; 2024 Aug 15; 91(2):255-258. PubMed ID: 38588818 [Abstract] [Full Text] [Related]
32. Significance of elevated serum LDH (lactate dehydrogenase) activity in atopic dermatitis. Mukai H, Noguchi T, Kamimura K, Nishioka K, Nishiyama S. J Dermatol; 1990 Aug 15; 17(8):477-81. PubMed ID: 2229651 [Abstract] [Full Text] [Related]
33. Sensitive skin is highly frequent in extrinsic atopic dermatitis and correlates with disease severity markers but not necessarily with skin barrier impairment. Yatagai T, Shimauchi T, Yamaguchi H, Sakabe JI, Aoshima M, Ikeya S, Tatsuno K, Fujiyama T, Ito T, Ojima T, Tokura Y. J Dermatol Sci; 2018 Jan 15; 89(1):33-39. PubMed ID: 29122406 [Abstract] [Full Text] [Related]
34. Skin barrier dysfunction and low antimicrobial peptide expression in cutaneous T-cell lymphoma. Suga H, Sugaya M, Miyagaki T, Ohmatsu H, Kawaguchi M, Takahashi N, Fujita H, Asano Y, Tada Y, Kadono T, Sato S. Clin Cancer Res; 2014 Aug 15; 20(16):4339-48. PubMed ID: 24919568 [Abstract] [Full Text] [Related]
35. Production of interleukin-2 by mononuclear cells in vitro in patients with atopic dermatitis and psoriasis. Comparison with serum interleukin-2 receptor levels. Kapp A, Neuner P, Krutmann J, Luger TA, Schöpf E. Acta Derm Venereol; 1991 Aug 15; 71(5):403-6. PubMed ID: 1684468 [Abstract] [Full Text] [Related]
36. Increased HMGB1 levels in lesional skin and sera in patients with cutaneous T-cell lymphoma. Senda N, Miyagaki T, Kamijo H, Nakajima R, Oka T, Takahashi N, Suga H, Yoshizaki A, Asano Y, Sugaya M, Sato S. Eur J Dermatol; 2018 Oct 01; 28(5):621-627. PubMed ID: 30378541 [Abstract] [Full Text] [Related]
37. Efficacy of ultraviolet A1 phototherapy on the expression of bcl-2 in atopic dermatitis and cutaneous T-cell lymphoma in vivo: a comparison study. Breuckmann F, von Kobyletzki G, Avermaete A, Kreuter A, Altmeyer P. Photodermatol Photoimmunol Photomed; 2002 Oct 01; 18(5):217-22. PubMed ID: 12390661 [Abstract] [Full Text] [Related]
38. Serum levels of anti-Staphylococcus aureus-specific IgE in patients with atopic dermatitis. Yamada H, Yudate T, Orita T, Tezuka T. J Clin Lab Immunol; 1996 Oct 01; 48(4):167-75. PubMed ID: 9819668 [Abstract] [Full Text] [Related]
39. Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells. Berger CL, Tigelaar R, Cohen J, Mariwalla K, Trinh J, Wang N, Edelson RL. Blood; 2005 Feb 15; 105(4):1640-7. PubMed ID: 15514008 [Abstract] [Full Text] [Related]
40. Association of serum interleukin-18 and other biomarkers with disease severity in adults with atopic dermatitis. Kou K, Aihara M, Matsunaga T, Chen H, Taguri M, Morita S, Fujita H, Yamaguchi Y, Kambara T, Ikezawa Z. Arch Dermatol Res; 2012 May 15; 304(4):305-12. PubMed ID: 22146836 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]